{
  "id": "5a981e66fcd1d6a10c00002f",
  "type": "list",
  "question": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors.",
  "ideal_answer": "Metabolic syndrome (MetS) is generally defined as a cluster of metabolically related cardiovascular risk factors which are often associated with the condition of insulin resistance, elevated blood pressure, and abdominal obesity.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26543426",
    "http://www.ncbi.nlm.nih.gov/pubmed/17137436",
    "http://www.ncbi.nlm.nih.gov/pubmed/16762931",
    "http://www.ncbi.nlm.nih.gov/pubmed/17125447",
    "http://www.ncbi.nlm.nih.gov/pubmed/18497723",
    "http://www.ncbi.nlm.nih.gov/pubmed/12137304",
    "http://www.ncbi.nlm.nih.gov/pubmed/12148078",
    "http://www.ncbi.nlm.nih.gov/pubmed/17469041",
    "http://www.ncbi.nlm.nih.gov/pubmed/23519746",
    "http://www.ncbi.nlm.nih.gov/pubmed/26280340",
    "http://www.ncbi.nlm.nih.gov/pubmed/11276389",
    "http://www.ncbi.nlm.nih.gov/pubmed/26871396",
    "http://www.ncbi.nlm.nih.gov/pubmed/19108808",
    "http://www.ncbi.nlm.nih.gov/pubmed/10682170",
    "http://www.ncbi.nlm.nih.gov/pubmed/28106792",
    "http://www.ncbi.nlm.nih.gov/pubmed/15827427",
    "http://www.ncbi.nlm.nih.gov/pubmed/15940204",
    "http://www.ncbi.nlm.nih.gov/pubmed/10863169",
    "http://www.ncbi.nlm.nih.gov/pubmed/23145009"
  ],
  "snippets": [
    {
      "text": " Metabolic syndrome (MetS) is a collection of clinical conditions, including central obesity, hypertension, glucose intolerance and dyslipidemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26871396",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic syndrome (MetS) is generally defined as a cluster of metabolically related cardiovascular risk factors which are often associated with the condition of insulin resistance, elevated blood pressure, and abdominal obesity",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28106792",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic syndrome, defined as a cluster of obesity, hypertension, dyslipidemia, and insulin resistance/glucose intolerance, has been identified as a major risk factor for coronary heart disease in women.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15827427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic syndrome is a cluster of conditions that synergistically increase the risk of cardiovascular disease, type 2 diabetes, and premature mortality. The components are abdominal obesity, impaired glucose metabolism, dyslipidemia, and hypertension.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26280340",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MetS is recognized clinically by numerous constitutive traits, including abdominal obesity, hypertension, dyslipidemia (elevated triglycerides, low high-density lipoprotein cholesterol), and hyperglycemia. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26543426",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Abdominal obesity is frequently associated with a collection of metabolic disorders that include elevated blood pressure, characteristic lipid abnormalities (low high-density lipoprotein cholesterol and high triglycerides) and increased fasting glucose, with an underlying situation of insulin resistance, which has been defined as metabolic syndrome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23519746",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The presence of 3 or more of the following 5 components (abdominal obesity, hypertriglyceridemia, low level of high density lipoprotein cholesterol, hypertension and high fasting blood glucose) allows to diagnose metabolic syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15940204",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The metabolic syndrome has 5 criteria: central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) levels, fasting hyperglycemia, and hypertension.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19108808",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic syndrome is a constellation of interrelated risk factors of metabolic origin including abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose level, and prothrombotic and proinflammatory states that promote atherosclerotic CVD and increase the risk of type 2 diabetes mellitus.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17125447",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The waist circumference cut points for diagnosing metabolic syndrome (as defined using the new harmonised guidelines), insulin resistance, dysglycaemia, hypertension and dyslipidaemia were obtained using receiver operator characteristic curve analysis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23145009",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The metabolic syndrome is a complex association of several risk factors including insulin resistance, dyslipidemia, and essential hypertension. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11276389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " insulin resistance syndrome (often referred to as syndrome X or the metabolic syndrome) ie, a clustering of metabolic, atheromatous risk factors, including hypertriglyceridaemia, hyperinsulinaemia, hyper-tension, hypercholesterinaemia and obesity. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12148078",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The metabolic syndrome is a clustering of risk factors which predispose an individual to cardiovascular morbidity and mortality. There is general consensus regarding the main components of the syndrome (glucose intolerance, obesity, raised blood pressure and dyslipidaemia [elevated triglycerides, low levels of high-density lipoprotein cholesterol]) ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17469041",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic syndrome (MS) refers to the clustering of cardiometabolic risk factors - including abdominal obesity, hyperglycaemia, dyslipidaemia and elevated blood pressure",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17137436",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The metabolic syndrome is a constellation of risk factors including glucose dysregulation, central obesity, dyslipidemia, and hypertension.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497723",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Insulin resistance syndrome (IRS), also termed syndrome X, is a distinctive constellation of risk factors for the development of type 2 diabetes mellitus and cardiovascular disease. The syndrome's hallmarks are glucose intolerance, hyperinsulinemia, a characteristic dyslipidemia (high triglycerides; low high-density lipoprotein cholesterol, and small, dense low-density lipoprotein cholesterol), obesity, upper-body fat distribution, hypertension, and increased prothrombotic and antifibrinolytic factors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10682170",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "\"The metabolic syndrome\" is the name for a clustering of risk factors for cardiovascular disease and type 2 diabetes that are of metabolic origin. These risk factors consist of atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose, a prothrombotic state, and a proinflammatory state. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16762931",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic Syndrome X is a clinical entity which comprises the following factors: diabetes mellitus, arterial hypertension, high levels of triglyceride and/or low levels of HDL cholesterol, central obesity and microalbuminuria",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12137304",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "metabolic syndrome, produced by genetic, hormonal and lifestyle factors such as obesity, physical inactivity and certain nutrient excesses. This disease is characterized by the clustering of insulin resistance and hyperinsulinemia, and is often associated with dyslipidemia (atherogenic plasma lipid profile), essential hypertension, abdominal (visceral) obesity, glucose intolerance or noninsulin-dependent diabetes mellitus and an increased risk of cardiovascular events",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10863169",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D024821",
    "https://meshb.nlm.nih.gov/record/ui?ui=D007333"
  ],
  "exact_answer": "obesity, hypertension, dyslipdemia"
}